NIH SBIR
Biotech Investor · 3 portfolio companies
Portfolio
3
Focus Areas
7
Top Stage
Pre-clinical
Portfolio Companies
| Company | Valuation |
|---|---|
| DirectSync Surgical | — |
| Amorphex Therapeutics | — |
| vivoVerse | — |
Biotech Investor · 3 portfolio companies
| Company | Valuation |
|---|---|
| DirectSync Surgical | — |
| Amorphex Therapeutics | — |
| vivoVerse | — |